Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Legacy Pharmaceutiucals | Contract Pharma
Breaking News, Promotions & Moves

Legacy Pharmaceutiucals

Paul Vaughan-Griffiths has been appointed to the newly created position of vice president of sales and marketing at Legacy Pharmaceuticals International, with the responsibility of overseeing sales and marketing in Europe, Middle East, Asia and Africa. He will be based at the company’s European headquarters in Basel, Switzerland.

“Legacy is excited to have Paul lead our EMEAA commercial efforts. We will continue to build on our momentum in the contract manufacturing business. This appointment underscores the depth of our commitment to global growth and continued profitability. The company will benefit from his expertise and leadership,” said Mr. Michael R. Danzi, Legacy’s chairman and chief executive officer.

Mr. Vaughan-Griffiths has more than 30 years’ experience in the pharmaceutical industry. Prior to joining Legacy he was head of commercial European operations in Prostrakan Ltd., where he was involved in building the European business. He also spent 10 years with Valeant Pharmaceuticals, where he was vice president sales, marketing and business development and helped build the European pharmaceutical business from $30 million to $250 million. He also spent 20 years working for American Cyanamid, Lederle Laboratories, in various sales, marketing and general management positions in Europe and the U.S.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters